Sun Pharmaceutical Industries Faces Mixed Trends Amid Sector Performance Challenges
Sun Pharmaceutical Industries has been active in the pharmaceuticals sector, closing near its 52-week low. The company, with a market capitalization of Rs 3,83,917.59 crore, has a P/E ratio below the industry average. Its recent performance shows mixed trends, with a notable decline over the past year.
Sun Pharmaceutical Industries has shown notable activity in the pharmaceuticals and biotechnology sector today, closing 2.96% away from its 52-week low of Rs 1555. The stock's performance today was in line with the sector, reflecting a modest decline of 0.15%, compared to a slight gain of 0.14% in the Sensex.Currently, Sun Pharmaceutical Industries holds a market capitalization of Rs 3,83,917.59 crore, categorizing it as a large-cap company. The stock's price-to-earnings (P/E) ratio stands at 33.52, which is below the industry average of 35.56.
In terms of moving averages, the stock is performing higher than its 5-day moving average but remains below the 20-day, 50-day, 100-day, and 200-day moving averages, indicating mixed short-term trends. Over the past year, the stock has experienced a decline of 14.11%, contrasting with the Sensex's performance of -1.32%.
Overall, Sun Pharmaceutical Industries has faced challenges in recent months, with a year-to-date performance of -15.09%, while its 3-year and 5-year performances remain positive at 84.19% and 208.48%, respectively.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
